Primary information |
---|
ID | antitb_1913 |
Peptide Name | None |
Sequence | ILSLRWRWKWWKK |
N-terminal Modification | Free |
C-terminal Modification | Free |
Chemical Modification | None |
Linear/ Cyclic | Linear |
Length | 13 |
Chirality | L |
Nature | Cationic |
Source | Synthetic |
Origin | NA |
Species | Mycobacterium tuberculosis |
Strain | Mycobacterium tuberculosis mc2 6020 |
Inhibition Concentartion | MIC = 32 μM |
In vitro/In vivo | In vitro |
Cell Line | J774.16 mouse macrophages and A549 human lung epithelial cells |
Inhibition Concentartion | NA |
Cytotoxicity | No cytotoxicity against J774.16 mouse macrophages and A549 human lung epithelial cells |
In vivo Model | NA |
Lethal Dose | NA |
Immune Response | NA |
Mechanism of Action | NA |
Target | Lipid bilayer |
Combination Therapy | NA |
Other Activities | Antibacterial against Streptococcus pyogenes, Streptococcus agalactiae, Streptococcus pneumoniae ATCC 49619, Klebsiella pneumoniae, Pseudomonas aeruginosa ATCC 27853, Bacillus subtilis BGSC 1A1. |
Pubmed ID | 26902758 |
Year of Publication | 2016 |
3-D Structure | NA |